Chengjun Li | Repair of musculoskeletal system injuries | Research Excellence Award

Posted on by Innovator Awards

Dr. Chengjun Li | Repair of musculoskeletal system injuries | Research Excellence Award

Xiangya Hospital, Central South University | China

The researcher is a clinician scientist trained through an integrated medical and surgical academic pathway, Repair of musculoskeletal system injuries with strong expertise in regenerative medicine, orthopaedic surgery, and neurorestorative science. Academic training and research have been conducted at leading medical institutions, with a focus on translational approaches that bridge basic science and clinical application. Research interests center on tissue engineering, musculoskeletal regeneration, neural repair, and mechanisms of organ injury and aging. Significant work has been devoted to studying biomaterials, stem cell based therapies, and regenerative strategies for bone, cartilage, and nerve repair, aiming to improve functional recovery following trauma and degenerative disease. The researcher has actively contributed to laboratory based and clinical studies under the mentorship of internationally recognized experts, demonstrating independence in experimental design, data interpretation, and scholarly communication. Professional experience includes postdoctoral research and clinical practice in a high volume hospital environment, enabling the integration of innovative therapies into patient care. Scholarly contributions have been recognized through multiple competitive academic honors and scholarships. Active participation in international scientific conferences, including oral presentations, reflects strong engagement with the global research community and a commitment to advancing regenerative medicine and surgical innovation through interdisciplinary collaboration.

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
738

Documents
30

h-index
16

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Huanghe Yu | Pharmacology | Best Researcher Award

Posted on by Innovator Awards

Dr. Huanghe Yu | Pharmacology | Best Researcher Award

Hunan University of Chinese Medicine | China

Huanghe Yu is a dedicated researcher whose work centers on uncovering the pharmacodynamics and therapeutic mechanisms of bioactive constituents from traditional Chinese medicine and ethnomedicine for managing rheumatoid arthritis, complemented by the innovation of biomimetic membrane-coated nano-targeted drug delivery systems for natural therapeutics. Recognized through multiple prestigious talent honors at regional and institutional levels, he also holds distinguished accolades for outstanding doctoral scholarship. His academic output reflects substantial influence, with more than thirty SCI-indexed publications, including a significant share as lead or corresponding author, several appearing in journals with impact factors above ten, along with multiple CSCD-core papers. His citation profile demonstrates strong visibility, with a citation count in the high hundreds and an h-index in the mid-teens, supported by a solid body of documents indexed across major databases. He has secured a diverse portfolio of competitive research funding spanning national, provincial, and institutional programs, demonstrating both leadership and continuity in advancing interdisciplinary work. Trained in clinical Chinese medicine with a focus on activity screening of traditional remedies and the development of advanced nano-delivery platforms for rheumatoid arthritis, he continues to integrate ethnopharmacology, nanotechnology, and translational medicine to shape innovative therapeutic strategies.

Profile: Scopus 

Featured Publications 


Author, A., Author, B., Author, C., et al. (2025). Treatment of rheumatoid arthritis by Rhododendron molle G. Don: The anti-inflammatory mechanism of its extract was elucidated by network analysis combined with experimental verification. BMC Complementary Medicine and Therapies.


Author, A., Author, B., Author, C., et al. (2025). Total saponins of Panax japonicus alleviate adjuvant-induced arthritis in rats by regulating macrophage polarization and intestinal microbiota. Journal of Ginseng Research.


Author, A., Author, B., Author, C., et al. (2025). Integrated network pharmacology and metabolomics to explore the mechanism of Kadsura coccinea root in alleviating acetaminophen-induced liver injury. Journal of Ethnopharmacology.


Author, A., Author, B., Author, C., et al. (2025). KadsuraChem: A machine learning-powered LC–MS database for Kadsura phytochemicals and its role in compound identification of Kadsura heteroclita. Journal of Agricultural and Food Chemistry.


Author, A., Author, B., Author, C., et al. (2025). Multifunctional Prussian blue nanoparticles loading with Xuetongsu for efficient rheumatoid arthritis therapy through targeting inflammatory macrophages and osteoclasts. Asian Journal of Pharmaceutical Sciences, 5

Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Posted on by Innovator Awards

Dr. Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Shiraz University| Iran

Mohammad Sadegh Taghizadeh is based at the Agricultural Faculty of Shiraz University (Institute of Biotechnology, Shiraz-Isfahan Highway, Shiraz, Iran) where he pursues advanced research in bioactive small molecules and peptides—whether synthesised by ribosomes or derived from proteins. His work spans in vitro isolation, purification and structural-physicochemical characterisation of these compounds, their pharmacological and sensory properties, and complementary in silico design and target-interaction studies. He also explores recombinant production of bioactive peptides using plant and bacterial expression systems. Prior to his current role, he earned a bachelor’s in agricultural engineering (plant protection) at Shahid Bahonar University of Kerman, a master’s in plant biotechnology at University of Guilan (thesis: factors affecting virulence genes of Agrobacterium tumefaciens in Arabidopsis thaliana mutants), and a PhD in biotechnology at Shiraz University (dissertation: functional properties of bio-active peptides derived from plant resources). He gained research experience at the Medical University of Vienna (on discovery of a novel cyclotide targeting the CCK2 receptor) and later led a project on plant-derived bioinsecticides funded by the National Elite Foundation of Iran, while also teaching as a TA in plant genetic engineering, molecular markers and plant tissue culture at Shiraz University. His research has steadily contributed to the field of peptide biotechnology, with growing recognition: his h-index currently stands at (unknown) and his publication and citation counts are steadily rising as he continues to establish himself in the realm of bioactive small molecules and recombinant peptide production.

Profile: Orcid  |  Scopus 

Featured Publications 

Abbasi, A., Taghizadeh, M. S., Moghadam, A., Niazi, A., Lotfi, M., & Taghavi, S.-M. (2025). A comprehensive insight into ultrasound-assisted protein extraction from Camelina sativa and de-bittering of resulting hydrolysates with emphasis on their structural, physicochemical, sensory, and biological properties. Food Chemistry, 445, 145435.

Taghizadeh, M. S., Niazi, A., Mirzapour-Kouhdasht, A., Pereira, E. C., & Garcia-Vaquero, M. (2025). Enhancing cyclotide bioproduction: Harnessing biological synthesis methods and various expression systems for large-scale manufacturing. Critical Reviews in Biotechnology, 45(1), 1–20.

Hoseini, S., Moghadam, A., Palizban, A., Hoseini, F., Taghizadeh, M. S., Choopani, A., & Hoseini, F. (2025). Immune boosting by pharmaceutical C-phycocyanin, in vitro and in silico effects on peripheral blood mononuclear cells. Health Biotechnology and Biopharma, 8(1), 1–10.

Lotfi, M., Keshvari, T., Taghizadeh, M. S., Afsharifar, A., Moghadam, A., Aram, F., & Niazi, A. (2025). Optimizing Camelina sativa oil extraction and its cytotoxicity using RSM by emphasis on antioxidant properties, physical characteristics, and molecular docking insights. Industrial Crops and Products, 215, 120334.

Taghizadeh, M. S., Mirzapour-Kouhdasht, A., & Huang, J.-Y. (2025, December). Unraveling the structure-activity relationship and molecular mechanisms for targeted therapeutic applications of food-derived angiotensin-I-converting enzyme inhibitory peptides. Food Bioscience, 65, 107820.

Ms. Chanchal Choudhary – Molecular and Developmental Biology – Best Researcher Award

Posted on by Innovator Awards

Ms. Chanchal Choudhary - Molecular and Developmental Biology - Best Researcher Award

Jawaharlal Nehru University - India 

Author Profile 

ORCID 

🎓 Early academic pursuits

Chanchal Choudhary’s academic journey began with a deep interest in molecular and developmental biology. She pursued a Doctor of Philosophy (PhD) in Life Sciences at Jawaharlal Nehru University, New Delhi. Her coursework, completed with an impressive CGPA of 8.06, laid a strong foundation in the intricacies of developmental biology. Her PhD research, titled "Understanding the role of TCTP2 in Dictyostelium discoideum," delved into the molecular dynamics of Translationally Controlled Tumor Protein (TCTP) and its critical role in various cellular processes.

🏢 Professional endeavors

Chanchal has amassed extensive experience in independent research and has been at the forefront of high-impact studies. Her work has led to several peer-reviewed publications and presentations at international conferences. This trajectory has not only honed her expertise but also positioned her as a leader in cross-functional projects. She has demonstrated a strong capability to mentor emerging scientists, fostering an environment of growth and innovation within her research teams.

🔬 Contributions and research focus

The cornerstone of Chanchal’s research lies in her in-depth exploration of TCTP2 in Dictyostelium discoideum. Her findings reveal the protein’s pivotal role in autophagy regulation, which is Molecular and Developmental Biology crucial for understanding cell proliferation, survival, and death. By elucidating the functions of TPT2, her research offers valuable insights into cellular dynamics and developmental biology. This study not only advances basic biological knowledge but also underscores the therapeutic potential of targeting TCTP in cancer treatment.

🌟 Accolades and recognition

Chanchal’s scholarly contributions have earned her recognition in the scientific community. Her research findings, published in esteemed journals, reflect her dedication and innovative Molecular and Developmental Biology approach. She has presented her work at prestigious international conferences, where she has been commended for her clarity and depth of knowledge. These accolades highlight her commitment to advancing the field of molecular and developmental biology.

🌍 Impact and influence

Chanchal’s work has significantly impacted the understanding of cellular processes in both basic and applied sciences. Her research on TCTP2 in Dictyostelium discoideum provides a Molecular and Developmental Biology framework for further studies on cell proliferation and autophagy. This has far-reaching implications for cancer research, potentially paving the way for novel therapeutic strategies. Her mentorship and collaborative projects have also influenced the next generation of scientists, fostering a culture of inquiry and discovery.

📚 Legacy and future contributions

Chanchal Choudhary’s legacy is rooted in her groundbreaking research and her dedication to the scientific community. As she continues her career, her future contributions are anticipated to further unravel the complexities of molecular biology and its applications in health and disease. Her ongoing commitment to addressing biological challenges through innovative research promises to leave a lasting impact on the field.

Notable Publications 

  • Title: Analyzing the functions of Translationally controlled tumor protein2 during growth, development and autophagy of Dictyostelium discoideum
    Authors: Chanchal Choudhary, Bhavya Jain, Shweta Saran
    Journal: Experimental Cell Research
    DOI: 10.1016/j.yexcr.2024.114400
    ISSN: 0014-4827
    Publication Date: January 2025
  • Title: In silico analysis of Translationally-Controlled Tumour Proteins of social amoeba Dictyostelium discoideum
    Authors: Chanchal Choudhary, Shweta Saran
    Journal: Biospectra
    DOI: 10.5281/ZENODO.14062730
    Publication Date: January 15, 2024

Dr. Vikas Shukla – Nanomedicine and Immunology – Best Researcher Award

Posted on by Innovator Awards

Dr. Vikas Shukla - Nanomedicine and Immunology - Best Researcher Award

AIIMS, New Delhi - India 

Author Profile

GOOGLE SCHOLAR 

Early academic pursuits 📚

Vikas Shukla's academic journey began with a deep-rooted passion for nanobiotechnology and immunology. He dedicated himself to gaining a solid foundation in the life sciences, eventually leading him to pursue advanced studies in these cutting-edge fields. His education, characterized by rigorous training, provided the tools necessary for his future contributions to scientific research. Over the years, vikas built an impressive knowledge base in bacterial culture, cell culture, and immunoassays, which would serve as the backbone of his research career.

Professional endeavors 🏢

currently serving as a research scientist-II at the all india institute of medical sciences (aiims) in new delhi, india, vikas brings over 8 years of extensive experience to the forefront. His role at aiims, within the department of plastic, reconstructive & burns surgery, involves not only laboratory-based research but also project management. This balance between hands-on science and overseeing project timelines ensures that he contributes effectively to the scientific and clinical goals of his department.

Contributions and research focus 🔬

Vikas's research primarily revolves around nanobiotechnology and immunology, with a keen focus on innovative solutions in medical science. He has demonstrated exceptional expertise in bacterial culture, cell culture, immunoassays, and small animal handling. His work seeks to bridge the gap between complex scientific Nanomedicine and Immunology theories and their real-world applications, particularly in healthcare. Vikas’s research outputs have helped advance understanding in both fundamental immunological responses and the application of nanotechnology in therapeutic treatments.

Accolades and recognition 🏅

throughout his career, vikas has received commendations for his meticulous work and contributions to the field. His ability to keep projects both on time and on Nanomedicine and Immunology budget while maintaining high scientific standards has not gone unnoticed. He is widely recognized among his peers and colleagues for his diligence, precision, and ability to translate complex scientific concepts into more accessible knowledge. His exceptional communication skills have further bolstered his reputation as a skilled researcher and project manager.

Impact and influence 🌍

Vikas’s research holds significant implications for the fields of immunology and nanobiotechnology, particularly within clinical settings. His work on developing innovative medical treatments and enhancing immunological responses has the potential to save lives and improve patient outcomes. His influence extends beyond the laboratory, as his project management skills ensure that critical research is completed efficiently, benefiting both the scientific community and society as a whole.

Legacy and future contributions 🔮

looking ahead, Vikas Shukla’s legacy will likely be defined by his contributions to advancing the use of nanotechnology in medicine. His ongoing work at aiims and within the broader scientific community will continue to impact the development of new therapeutic approaches and enhance our understanding of immune Nanomedicine and Immunology responses. His commitment to pushing the boundaries of science while managing complex projects ensures that his influence will be felt for years to come.

Notable Publications 

Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives  2021

Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology  2023

Downmodulation of lysophosphatidic acid by Berberine loaded folate-conjugated glycol chitosan nanoparticles  2022

Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects  2022

Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment 2024